A demonstration project of oral PrEP for young women, conducted in six African countries with high HIV prevalence, achieved high levels of PrEP uptake and persistence, and good levels of adherence among its 3000 participants.
Dr Brenda Mirembe of Makerere University told the Conference on Retroviruses and Opportunistic Infections (CROI 2024) that the use of a rapid urine test to measure tenofovir levels and confirm adherence was generally seen as supportive by the participants. But despite high levels of PrEP use, HIV annual incidence remained quite high at 1.38% – or one infection in every 72 participants a year. This is not much lower than the current estimated incidence among young women in South Africa (about 1.5% a year).
Read the full story at Aidsmap.
SEE ALSO:
Source : Aidsmap
Related HIV and Co-Infections News
-
[BHIVA/BASHH 2026] HIV i-Base: Liverpool University launches new PrEP drug interaction website: covers oral, injectable and ring-based PrEP
-
[BHIVA/BASHH 2026] HIV i-Base: Limited drug resistance after doxyPEP but inequitable access: uptake of 4CMenB vaccine
-
HIV i-Base: Transgender health in Australia: HIV drops by 94% as PrEP increases over 10 years
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.